Restoring OTC Eligibility For Health Savings Could Fly During Lame Duck Session
This article was originally published in The Tan Sheet
Rep. Barrow says congressional gridlock is blocking the Restoring Access to Medication Act, but there is hope for passage during the lame duck session. CHPA and self-care advocates discuss the need for the change and the value of OTCs during briefing marking International Self-Care Day.
You may also be interested in...
The Consumer Healthcare Products Association’s No. 1 legislative priority in 2014 is restoring OTC coverage by flexible spending and health savings accounts, followed by a “close No. 2” goal of establishing an age requirement to buy DXM products. Other goals include protecting access to PSE products and blocking take-back programs.
Information from the CHPA-commissioned study could help improve policymakers’ understanding of the costs of making OTCs less available as well as the benefits of more Rx-to-OTC switches.
J&J reports worldwide consumer sales dipped 0.6% to $3.6 billion despite retailers buying more upper respiratory and analgesic products to prepare for the cough and cold season. But in key OTC categories the firm is regaining market share it lost when its iconic brands were temporarily not available.